J

Joinn Laboratories China Co Ltd
SSE:603127

Watchlist Manager
Joinn Laboratories China Co Ltd
SSE:603127
Watchlist
Price: 19.5 CNY -0.51% Market Closed
Market Cap: 12.3B CNY
Have any thoughts about
Joinn Laboratories China Co Ltd?
Write Note

Balance Sheet

Balance Sheet Decomposition
Joinn Laboratories China Co Ltd

Current Assets 5.5B
Cash & Short-Term Investments 3.4B
Receivables 358.7m
Other Current Assets 1.7B
Non-Current Assets 4.2B
Long-Term Investments 2.2B
PP&E 1.5B
Intangibles 435.5m
Other Non-Current Assets 106.5m
Current Liabilities 1.5B
Accounts Payable 64.6m
Accrued Liabilities 93.1m
Other Current Liabilities 1.4B
Non-Current Liabilities 227.1m
Long-Term Debt 29m
Other Non-Current Liabilities 198.1m

Balance Sheet
Joinn Laboratories China Co Ltd

Rotate your device to view
Balance Sheet
Currency: CNY
Dec-2014 Dec-2015 Dec-2016 Dec-2017 Dec-2018 Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
51
63
133
405
149
177
305
4 150
2 899
2 854
Cash
0
0
0
0
0
0
0
4 150
2 899
2 854
Cash Equivalents
51
63
133
405
149
177
305
0
0
0
Short-Term Investments
0
0
0
1
103
131
239
681
408
1 907
Total Receivables
24
17
20
31
54
122
171
232
358
368
Accounts Receivables
23
17
17
26
39
106
156
207
328
333
Other Receivables
2
0
3
5
15
15
15
25
31
35
Inventory
37
52
64
92
115
217
406
701
2 195
1 863
Other Current Assets
17
18
24
69
270
11
62
51
67
130
Total Current Assets
129
150
241
597
690
657
1 183
5 814
5 928
7 122
PP&E Net
268
270
308
295
391
487
547
849
1 779
1 576
PP&E Gross
0
0
308
295
391
487
547
849
1 779
1 576
Accumulated Depreciation
0
0
109
131
155
186
234
329
430
530
Intangible Assets
44
43
42
43
48
107
124
137
300
292
Goodwill
0
0
0
0
0
134
125
122
134
136
Long-Term Investments
0
0
0
0
0
12
64
1 536
2 146
798
Other Long-Term Assets
10
19
5
6
13
47
65
77
78
103
Other Assets
0
0
0
0
0
134
125
122
134
136
Total Assets
452
N/A
482
+7%
597
+24%
941
+58%
1 141
+21%
1 444
+27%
2 108
+46%
8 537
+305%
10 364
+21%
10 027
-3%
Liabilities
Accounts Payable
15
10
20
13
20
44
60
54
127
43
Accrued Liabilities
15
17
19
24
31
53
57
84
135
113
Short-Term Debt
11
0
0
0
0
11
0
0
0
0
Current Portion of Long-Term Debt
38
0
0
0
0
2
3
26
28
27
Other Current Liabilities
130
164
214
275
358
373
639
1 051
1 555
1 284
Total Current Liabilities
208
191
252
311
409
483
760
1 214
1 844
1 467
Long-Term Debt
0
0
0
0
0
9
21
69
60
42
Deferred Income Tax
0
0
0
0
2
24
35
48
188
162
Minority Interest
0
0
0
0
0
1
1
8
7
2
Other Liabilities
85
83
85
72
78
78
67
61
81
74
Total Liabilities
293
N/A
274
-6%
337
+23%
383
+14%
490
+28%
594
+21%
883
+49%
1 401
+59%
2 181
+56%
1 748
-20%
Equity
Common Stock
61
61
61
82
115
162
228
381
536
750
Retained Earnings
38
87
139
215
299
469
729
1 189
2 125
2 308
Additional Paid In Capital
60
60
60
261
246
233
250
5 544
5 480
5 267
Unrealized Security Profit/Loss
0
0
0
0
0
0
0
47
92
93
Treasury Stock
0
0
0
0
10
14
10
4
53
146
Other Equity
0
0
0
1
1
1
29
21
3
7
Total Equity
159
N/A
208
+31%
260
+25%
557
+115%
651
+17%
850
+30%
1 225
+44%
7 136
+483%
8 184
+15%
8 279
+1%
Total Liabilities & Equity
452
N/A
482
+7%
597
+24%
941
+58%
1 141
+21%
1 444
+27%
2 108
+46%
8 537
+305%
10 364
+21%
10 027
-3%
Shares Outstanding
Common Shares Outstanding
168
168
168
225
225
226
227
746
749
744

See Also

Discover More